CoChat
Sign Up
Cited by 79Atrial Fibrillation Management and OutcomesCardiac electrophysiology and arrhythmiasCardiac Arrhythmias and Treatments

Atrial fibrillation and anabolic steroid abuse

Lau, Dennis H., Stiles, Martin K., John, Bobby, Shashidhar, Young, Glenn D., Sanders, Prashanthan·2007·International Journal of Cardiology
DOI 10.1016/j.ijcard.2006.11.199
Open this paper in CoChat — free account

Abstract

Atrial fibrillation (AF) is the most common sustained arrhythmia to occur in humans. Several predisposing substrates such as increasing age, heart failure, hypertension and valvular heart disease have been identified. The use of illicit drugs as the substrate for AF is not frequently recognized.

Integrity signals

Registry

Crossref · 10.1016/j.ijcard.2006.11.199

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Non-approved anabolic steroids are used at competitive levels to improve performance and are associated with an increased risk of AF in young athletes.

    “Non-approved anabolic steroids are being used at competitive levels in order to improve performance, and have been associated with an increased risk of AF in young athletes [39,40].”

    From Atrial Fibrillation in Elite Athletes: A Comprehensive Review of the Literature (2024) · cites this paper as [40]

Cited by

Sorted by citations

Authors
Lau, D. H., Stiles, M. K., John, B., Shashidhar, Young, G. D., & Sanders, P.
Affiliations
Royal Adelaide Hospital (AU)
Corresponding author
Sanders, Prashanthan
ORCID
Venue
International Journal of Cardiology
Publisher
Elsevier BV
Published
2007-04
Volume
117
Issue
2
Pages
e86-e87
ISSN
0167-5273 (ISSN-L)
DOI
10.1016/j.ijcard.2006.11.199
OpenAlex
W2143004334
Cited by
79
References
0
Citations by year
2026: 1 · 2025: 2 · 2024: 4 · 2022: 6 · 2021: 4 · 2020: 2 · 2019: 3 · 2018: 5 · 2017: 3 · 2016: 3 · 2015: 5 · 2014: 9 · 2013: 10 · 2012: 7
FWCI
3.29
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • International Journal of Cardiology (publishedVersion)
  • PubMed (publishedVersion)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
Funders
  • University of Adelaide
  • Royal Adelaide Hospital
  • National Heart Foundation of Australia
  • National Heart Foundation of New Zealand
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
Keywords
atrial fibrillation, anabolic steroids, illicit drug use, cardiac arrhythmias, risk factors, drug-induced arrhythmia
MeSH terms
Adult, Atrial Fibrillation, Humans, Male, Stanozolol, Testosterone, Substance-Related Disorders, Anabolic Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review